Welcome to the “Golden Age” of PN: Ruxolitinib Cream 1.5% (Opzelura, Incyte) Shows Early Improvement in Itch and Skin Lesions March 8, 2025
Spesolimab (Spevigo, Boehringer Ingelheim) Improves Physical Symptoms and QofL for GPP Patients March 8, 2025
Unpacking the Latest Results From The ADORING 3 Study of Tapinarof in AD With Linda Stein Gold, MD March 8, 2025